MOBKL1A inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of MOBKL1A, also known as MOB1A, a key component in the regulation of cell signaling pathways involved in cell growth, division, and survival. MOBKL1A is part of the MOB (Mps One Binder) family of proteins, which are involved in the activation of the Hippo signaling pathway, a critical regulator of organ size, tissue homeostasis, and the balance between cell proliferation and apoptosis. MOBKL1A functions by binding to and activating key components of the Hippo pathway, such as the kinase LATS1/2, which in turn regulate the activity of transcription factors that control gene expression involved in cell growth and differentiation. By inhibiting MOBKL1A, researchers can disrupt these signaling pathways, providing insights into the role of MOBKL1A in maintaining proper cellular function and tissue organization.
In research settings, MOBKL1A inhibitors are valuable tools for investigating the molecular mechanisms by which the Hippo signaling pathway governs cellular behavior and the broader implications of disrupting MOBKL1A activity on cell proliferation and survival. By blocking MOBKL1A activity, scientists can explore how the inhibition impacts the phosphorylation and activation of downstream targets such as LATS kinases and YAP/TAZ transcription factors, key players in cell growth regulation. This inhibition allows researchers to study the effects on cellular processes such as apoptosis, contact inhibition, and cellular differentiation, which are tightly controlled by the Hippo pathway. Additionally, MOBKL1A inhibitors provide insights into how MOBKL1A interacts with other regulatory proteins in the Hippo network and its broader role in coordinating growth control in response to mechanical and biochemical signals. Through these studies, the use of MOBKL1A inhibitors enhances our understanding of the intricate regulation of cell signaling pathways involved in growth control, tissue architecture, and cellular homeostasis, and offers a deeper look into the molecular processes that balance cell proliferation and cell death.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may inhibit MOB1B expression by interfering with RNA polymerase activity, potentially disrupting the transcription of MOB1B mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide is suggested to inhibit MOB1B expression by interfering with protein synthesis, potentially leading to decreased levels of MOB1B. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin may inhibit MOB1B expression by incorporating into the growing peptide chain during protein synthesis, leading to reduced MOB1B levels. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin could potentially inhibit MOB1B expression by interfering with protein synthesis, potentially leading to decreased levels of MOB1B. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin is suggested to inhibit MOB1B expression by inducing DNA damage and triggering cellular stress responses that may downregulate MOB1B transcription. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide may inhibit MOB1B expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased MOB1B transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin is suggested to inhibit MOB1B expression by inducing DNA damage and triggering cellular stress responses that may downregulate MOB1B transcription. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin may inhibit MOB1B expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased MOB1B transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine could potentially inhibit MOB1B expression by inducing DNA damage and interfering with the function of key transcriptional regulators of MOB1B. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C is suggested to inhibit MOB1B expression by inducing DNA damage and triggering cellular stress responses that may downregulate MOB1B transcription. | ||||||